Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Scope: Recent data suggest that gut microbiota contributes to the regulation of host lipid metabolism. We report how fermentable dietary fructo‐oligosaccharides (FOS) control hepatic steatosis induced by n‐3 PUFA depletion, which leads to hepatic alterations similar to those observed in non‐alcoholic fatty liver disease patients. Methods and results: C57Bl/6J mice fed an n‐3 PUFA‐depleted diet for 3 months were supplemented with FOS during the last 10 days of treatment. FOS‐treated mice exhibited higher caecal B ifidobacterium spp. and lower R oseburia spp. content. Microarray analysis of hepatic m RNA revealed that FOS supplementation reduced hepatic triglyceride accumulation through a proliferator‐activated receptor α‐stimulation of fatty acid oxidation and lessened cholesterol accumulation by inhibiting sterol regulatory element binding protein 2‐dependent cholesterol synthesis. Cultured precision‐cut liver slices confirmed the inhibition of fatty acid oxidation. FOS effects were related to a decreased hepatic micro‐RNA 33 expression and to an increased colonic glucagon‐like peptide 1 production. Conclusions: The changes in gut microbiota composition by n‐3 PUFA‐depletion and prebiotics modulate hepatic steatosis by changing gene expression in the liver, a phenomenon that could implicate micro‐RNA and gut‐derived hormones. Our data underline the advantage of targeting the gut microbiota by colonic nutrients in the management of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518
Self-citationHuman Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 1×
“fibrosis and cirrhosis [1].”
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338 · cited 1×
“Moreover, cholesterol accumulation is proposed to participate to the pathogenesis of NAFLD and non-alcoholic steatohepatitis [2, 3].”
BackgroundRole of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
ARAYA, J., RODRIGO, R., VIDELA, L. A., THIELEMANN, L., ORELLANA, M., PETTINELLI, P., & PONIACHIK, J. (2004) · Clinical Science · doi:10.1042/cs20030326 · Cited by 700
Svegliati‐Baroni, G., Saccomanno, S., Rychlicki, C., Agostinelli, L., De Minicis, S., Candelaresi, C., Faraci, G., Pacetti, D., Vivarelli, M., Nicolini, D., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02462.x · Cited by 405 · cited 1×
“Accordingly, recent data reported that hepatocytes isolated from high-fat fed rat and incubated with an agonist of the GLP-1 receptor, exenatide, exhibited a reduced lipid accumulation and a stimulation of the fatty acid oxidative pathway mediated by PPAR [47].”
BackgroundExpression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I. A., MacDougald, O. A., & Bommer, G. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152090 · Cited by 382 · cited 2×
“In addition, we have measured the expression of microRNA 33 (miR-33) as it is present in the SREBP-2 primary transcript intron and that it has been shown to modulate hepatic lipid metabolism and to contribute to hepatic lipid accumulation [29].”
BackgroundSelf-citationEnhanced free cholesterol, SREBP-2 and StAR expression in human NASH
Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368 · cited 1×
“Moreover, cholesterol accumulation is proposed to participate to the pathogenesis of NAFLD and non-alcoholic steatohepatitis [2, 3].”
BackgroundHepatic lipid metabolism and non-alcoholic fatty liver disease
Tessari, P., Coracina, A., Cosma, A., & Tiengo, A. (2009) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.015 · Cited by 314 · cited 1×
“Hepatic steatosis may also result from nutritional imbalance, including high carbohydrate, high saturated fatty acid and/or high cholesterol dietary intake [5].”
Kondo, T., Kishi, M., Fushimi, T., & Kaga, T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900470c · Cited by 301
Xie, N., Cui, Y., Yin, Y.-N., Zhao, X., Yang, J.-W., Wang, Z.-G., Fu, N., Tang, Y., Wang, X.-H., Liu, X.-W., et al. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-53 · Cited by 211
Cited by
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“Most recently, the group of Cani and Delzenne showed that prebiotic fructo-oligosaccharides (FOS) attenuate experimental hepatic steatosis, possibly by modulating the intestinal microbiota or the intestinal barrier function or both [103].”
BackgroundNext-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
Cani, P. D., & de Vos, W. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01765 · Cited by 1,058
Self-citationDiabetes, obesity and gut microbiota
Everard, A., & Cani, P. D. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.007 · Cited by 543
Self-citationGut microbiome and liver diseases
Tilg, H., Cani, P. D., & Mayer, E. A. (2016) · Gut · doi:10.1136/gutjnl-2016-312729 · Cited by 525
Self-citationThe links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
Safari, Z., & Gérard, P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03011-w · Cited by 502
Metadata
- Authors
- Pachikian, B. D., Essaghir, A., Demoulin, J., Catry, E., Neyrinck, A. M., Dewulf, E. M., Sohet, F. M., Portois, L., Clerbaux, L., Carpentier, Y. A., Possemiers, S., Bommer, G. T., Cani, P. D., & Delzenne, N. M.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2012-12-02
- Volume
- 57
- Issue
- 2
- Pages
- 347-359
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2156445392
- Cited by
- 98
- References
- 11
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.